28 Dec 2014
Indian Biosimilar market valuation
Indian biosimilar market is around 2000 Crores.
Percentage of Biosimilar market over total pharma market
Who are the leading players in Indian biosimilar market?
- Biocon – Streptokinase, EPO Filgrastim, MAbs
- Zydus – Insulin, Streptokinase, Filgrastim
- DRL – Rituximab, Filgrastim, Darbepoetin alfa
- Lupin – EGFR, Abciximab
- Ranbaxy – EPO Filgrastim, Interferon, Infliximab
- Wockhardt – Insulin, EPO, Insulin Glargine
Panacea Biotech, Bharat Biotech also has strong presence.